Yourgene Health PLC - Manchester, England-headquartered molecular diagnostics firm - Signs contract with partner Cytox Ltd for Yourgene Genomic Services to run Cytox's genetic test, genoSCORE-LAB, which can predict the risk of someone's cognitive decline due to Alzheimer's disease.
The test uses a blood or saliva sample to conduct testing.
"We are pleased to update shareholders on this exciting development with our partner Cytox, highlighting the strengths and scope of our YGS capabilities. This is an additional test in our growing portfolio around precision health and provides another endorsement of the CRO core services offering YGS provides to our partners," notes Chief Executive Officer Lyn Rees.
Current stock price: 16.25 pence
Year-to-date change: up 10%
By Dayo Laniyan; dayolaniyan@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
